CD4 and rheumatoid arthritis: In spite of the immunomodulatory and immunosuppressive treatments that these patients received, we observed no overall significant differences in the CD4+ T-cell responses elicited by the 2015 seasonal vaccine between RA patients on biologics and healthy controls (Fig. 6; Supplementary Fig. 10).